We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Vyalev
Australian Public Assessment Report
Device/Product Name
Vyalev
Active ingredients
Foslevodopa and Foscarbidopa
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-03724-1-1
Submission Type
New fixed dose combination medicine Vyalev, containing 2 new chemical entities (foslevodopa and foscarbidopa)
Decision
Approved